Inhibition of angiogenesis by blockers of volume-regulated anion channels

General Pharmacology

Volumn 34, Issue 2, 2000, Pages 107-116

  Manolopoulos, Vangelis G ^a,b   Liekens, Sandra ^c   Koolwijk, Pieter ^d   Voets, Thomas ^b   Peters, Erna ^d   Droogmans, Guy ^b   Lelkes, Peter I ^e   De Clercq, Erik ^c   Nilius, Bernd ^b  

^a DEMOCRITUS UNIVERSITY OF THRACE MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^d TNO   (Netherlands)

^e UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

Author keywords

Angiogenesis; Clomiphene; Endothelial cells; Mibefradil; NPPB; Tamoxifen; Volume regulated anion channels

Indexed keywords

5 NITRO 2 (3 PHENYLPROPYLAMINO)BENZOIC ACID; ANGIOGENESIS INHIBITOR; ANION CHANNEL; CLOMIFENE; FIBROBLAST GROWTH FACTOR; MATRIGEL; MIBEFRADIL; TAMOXIFEN; TUMOR NECROSIS FACTOR ALPHA;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; BLOCKING FACTOR; CELL SWELLING; CHORIOALLANTOIS; CONTROLLED STUDY; DRUG POTENCY; ENDOTHELIUM CELL; HUMAN; HUMAN TISSUE; INHIBITION KINETICS; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR RING;

ALLANTOIS; ANGIOGENESIS INHIBITORS; ANIMALS; AORTA, THORACIC; CATTLE; CELLS, CULTURED; CHICK EMBRYO; CHORION; CLOMIPHENE; COLLAGEN; DRUG COMBINATIONS; ENDOTHELIUM, VASCULAR; FIBRIN; HUMANS; ION CHANNELS; LAMININ; MALE; MIBEFRADIL; NEOVASCULARIZATION, PHYSIOLOGIC; NITROBENZOATES; PROTEOGLYCANS; RATS; RATS, WISTAR; TAMOXIFEN;

EID: 0033849261     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(00)00052-5     Document Type: Article

References (37)

1. Alliegro M.C., Alliegro M.A., Cragoe E.J., Glaser B.M. Amiloride inhibition of angiogenesis in vitro. J Exp Zool. 267:1993;245-252.
2. Augustin H.G. Antiangiogenic tumour therapy. will it work? Trends Pharamacol Sci. 19:1998;216-222.
3. Baatout S. Endothelial differentiation using matrigel. Anticancer Res. 17:1997;451-455.
4. Cabantchik Z.I., Greger R. Chemical probes for anion transporters of mammalian cell membranes. Am J Physiol. 262:1992;C803-C827.
5. D'Amore P.A., Thompson R.N. Mechanism of angiogenesis. Annu Rev Physiol. 49:1987;453-464.
6. Dvorak H.F., Nagy J.A., Berse B., Brown L.F., Yeo K.T., Dvorak A.M., Vandewater L., Sioussat T.M., Senger D.R. Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation. Ann N Y Acad Sci. 667:1992;101-111.
7. Folkman J. Clinical applications of research on angiogenesis. N Engl J Med. 333:1995;1757-1763.
8. Folkman J., Klagsbrun M. Angiogenic growth factors. Science. 235:1987;442-447.
9. Furman Haran E., Maretzek A.F., Goldberg I., Horowitz A., Degani H. Tamoxifen enhances cell death in implanted MCF7 breast cancer by inhibiting endothelium growth. Cancer Res. 54:1994;5511-5514.
10. Gagliardi A., Collins D.C. Inhibition of angiogenesis by antiestrogens. Cancer Res. 53:1993;533-535.
11. Gagliardi A., Hennig B., Collins D.C. Antiestrogens inhibit endothelial cell growth stimulated by angiogenic growth factors. Anticancer Res. 16:1996;1101-1106.
12. Grainger D.J., Weissberg P.L., Metcalfe J.C. Tamoxifen decreases the rate of proliferation of rat vascular smooth muscle cells in culture by inducing production of transforming growth factor β Biochem J. 294:1993;109-112.
13. Harris-Hooker S.A., Gajdusek C.M., Wight T.N., Schwartz S.M. Neovascular response induced by cultured aortic endothelial cells. J Cell Physiol. 114:1983;302-310.
14. Hyder S.M., Chiappetta C., Stancel G.M. Triphenylethylene antiestrogens induce uterine vascular endothelial growth factor expression via their partial estrogen agonist activity. Cancer Lett. 120:1997;165-171.
15. Kaneko T., Nagata I., Miyamoto S., Kubo H., Kikuchi H., Fujisato T., Ikada Y. Effects of nicardipine on tube formation of bovine vascular endothelial cells in vitro. Stroke. 23:1992;1637-1642.
16. Kohn E.C., Alessandro R., Spoonster J., Wersto R.P., Liotta L.A. Angiogenesis. role of calcium-mediated signal transduction Proc Natl Acad Sci USA. 92:1995;1307-1311.
17. Koolwijk P., Van Erck M.G.M., De Vree W.J.A., Vermeer M.A., Weich H.A., Hanemaaijer R., van Hinsbergh V.W.M. Cooperative effect of TNFα, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. role of urokinase activity J Cell Biol. 132:1996;1177-1188.
18. Kubota Y., Kleinman H.K., Martin G.R., Lawley T.J. Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures. J Cell Biol. 107:1988;1589-1598.
19. Lansink M., Koolwijk P., van Hinsbergh V., Kooistra T. Effect of steroid hormones and retinoids on the formation of capillary-like tubular structures of human microvascular endothelial cells in fibrin matrices is related to urokinase expression. Blood. 92:1998;927-938.
20. Liekens S., Neyts J., Degreve B., De Clercq E. The sulfonic acid polymers PAMPS [Poly(2-acrylamido-2-methyl-1-propane-sulfonic acid)] and related analogues are highly potent inhibitors of angiogenesis. Oncol Res. 9:1997;173-181.
21. Lindner D.J., Borden E.C. Effects of tamoxifen and interferon-β or the combination on tumor-induced angiogenesis. Int J Cancer. 71:1997;456-461.
22. i protein. Biochim Biophys Acta. 1356:1997;321-332. a.
23. Manolopoulos V.G., Voets T., Declercq P.E., Droogmans G., Nilius B. Swelling-activated efflux of taurine and other organic osmolytes in endothelial cells. Am J Physiol. 273:1997;C214-C222. b.
24. 2+ channels by Ro 40-5967. Circ Res. 75:1994;144-148.
25. Nguyen M., Shing Y., Folkman J. Quantitation of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane. Microvasc Res. 47:1994;31-40.
26. Nicosia R.F., Ottinetti A. Growth of microvessels in serum-free matrix culture of rat aorta. a quantitative assay of angiogenesis in vitro Lab Invest. 63:1990;115-122.
27. Nicosia R.F., Villaschi S. Autoregulation of angiogenesis by cells of the vessel wall. Int Rev Cytol. 185:1999;1-43.
28. - current by hypotonic volume increase in human endothelial cells. J Gen Physiol. 103:1994;787-805. a.
29. - currents in different mammalian non-excitable cell types. Pfluegers Arch. 428:1994;364-371. b.
30. Nilius B., Eggermont J., Voets T., Buyse G., Manolopoulos V., Droogmans G. Properties of volume-regulated anion channels in mammalian cells. Prog Biophys Mol Biol. 68:1997;69-119. a.
31. - channels in macrovascular endothelial cells. Br J Pharmac. 121:1997;547-555. b.
32. Nilius B., Szücs G., Heinke S., Voets T., Droogmans G. Multiple types of chloride channels in bovine pulmonary artery endothelial cells. J Vasc Res. 34:1997;220-228. c.
33. Pipili-Synetos E., Sakkoula E., Haralabopoulos G., Andriopoulou P., Peristeris P., Maragoudakis M.E. Evidence that nitric oxide is an endogenous antiangiogenic mediator. Br J Pharmac. 111:1994;894-902.
34. Silva I.D.C.G., Salicioni A.M., Russo I.H., Higgy N.A., Gebrim L.H., Russo J. Tamoxifen down-regulates CD36 messenger RNA levels in normal and neoplastic human breast tissues. Cancer Res. 57:1997;378-381.
35. Szücs G., Buyse G., Eggermont J., Droogmans G., Nilius B. Characterisation of volume-activated chloride currents in endothelial cells from bovine pulmonary artery. J Membr Biol. 149:1996;189-197.
36. - currents inhibit endothelial cell proliferation. Pfluegers Arch. 431:1995;132-134.
37. Ziche M., Morbidelli L., Masini E., Amerini S., Granger H.J., Maggi C.A., Geppetti P., Ledda F. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest. 94:1994;2036-2044.